Nicholas Donoghoe has not been actively trading shares of AbbVie during the past quarter. Most recently, on Thursday, August 29th, Nicholas Donoghoe bought 7,525 shares of AbbVie stock. The stock was acquired at an average cost of $66.19 per share, with a total value of $498,079.75. Following the completion of the transaction, the senior vice president now directly owns 13,090 shares of the company's stock, valued at $866,427.10. Learn More on Nicholas Donoghoe's trading history.